<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220401054386N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-28</date_registration>
      <primary_sponsor>The University of Faisalabad</primary_sponsor>
      <public_title>Comparison of Kinesiology Taping and Mulligan's Pain Release Phenomena in patients having De Quervain's Tenosynovitis symptoms.</public_title>
      <acronym></acronym>
      <scientific_title>Comparative Effect of Kinesiology Taping and Mulligan’s Pain Release Phenomena in patient having De Quervain’s Tenosynovitis: A Randomized Clinical Trial.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63253</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Treatment, Randomization description: 30 subjects will be taken and divided into 2 groups by simple randomization. In a random sample, each individual unit has an equal chance of getting selected. Similarly, in a lottery method, each individual unit is selected at random from the population and thereby has an equal opportunity of getting selected. Randomization is done by lottery method, sealed envelop will made upon which allocation of participants in both groups can be possible without biasness. Lottery method always gives a random sample's outcome. 
A researcher randomly picks numbers, with each number corresponding to a subject or item, in order to create the sample. To create a sample this way, the researcher must ensure that the numbers are well mixed before selecting the sample population. Concealed allocation will  be carried out, Blinding description: Participants of both groups will be unaware weather they are in active control or treatment group after the informed consent has been taken from them. Participants of both group will receive the same baseline treatment that is Ultrasound. After that Physiotherapist will apply Kinesiology Taping to one group and Mulligan Pain Release Phenomena to other group of which the participants will be unaware.</study_design>
      <phase>N/A</phase>
      <hc_freetext>De Quervain’s Tenosynovitis most commonly occurring cause of wrist and hand pain, commonly tendonitis of wrist.De Quervain’s Tenosynovitis is a condition commonly occurring due to pathology of tendon of abductor pollicis longus and extensor pollicis brevis. De Qurvain’s Tenosynovitis occur with symptoms as the pain over radial styloid that increases with movement of thumb with the tenderness experienced over the first dorsal compartment. De Quervain’s Tenosynovitis may be occurred either due to any acute and sudden trauma or may be more often as a result of repetitive microtrauma..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: A (Kinesiology Taping Group) receive baseline treatment include Therapeutic Ultrasound for 10 minutes, then Kinesiology Taping is applied for 6 weeks. Patient will  received Kinesiology Taping 4 times per week . Intervention 2: Intervention group: B (Mulligan's Pain Release Phenomena) all subjects in this will receive baseline treatment include Therapeutic Ultrasound 10 minutes, then Mulligan’s Pain Release Phenomena. PRP will apply for 6 weeks .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All collected deidentified participants data set for the outcomes measure.

When:
4 month after publication

To whom:
People working in the academic institutions .

Conditions:
IPD and any additional supporting documents will be provided for the research on the similar topic and can be obtained by asking through contact person mentioned below.

Where to obtain:
Contact Person : Asma Sattar. Contact number:03161614659 Email: asmatalat23@yahoo.com

How to obtain:
Data file will be provided after talking to contact person as mentioned in the above slot.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Sidra Majeed ; PT</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>4km-Sargodha Road, University Town , Faisalabad</address>
        <city>Faisalabd</city>
        <country1>Pakistan</country1>
        <zip>38000</zip>
        <telephone>+92 334 7731241</telephone>
        <email>sidra.majeed@tuf.edu.pk</email>
        <affiliation>The University Of Faisalabad</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Asma Sattar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>House no 04, F block Nayab City Multan</address>
        <city>Multan</city>
        <country1>Pakistan</country1>
        <zip>60000</zip>
        <telephone>+92 316 1614659</telephone>
        <email>dpt-fa11-021@tuf.edu.pk</email>
        <affiliation>The University of Faisalabad</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
      <country2>Pakistan</country2>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patient who are willing to participate.
Age 20 - 40 years.
Male and Female Patients.
Patient having mild to moderate pain 3 to 6 according to NPR.
Difficulty moving the thumb (with Positive Finkelstein test).</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patient with recent fracture of wrist.
Patient with fixed contracture of wrist.
Patient with open wounds.
Patient having perceptive and cognitive disorders.
Patient who are not willing to participate.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: A (Kinesiology Taping Group) receive baseline treatment include Therapeutic Ultrasound for 10 minutes, then Kinesiology Taping is applied for 6 weeks. Patient will  received Kinesiology Taping 4 times per week .</i_keyword>
      <i_keyword>Intervention group: B (Mulligan's Pain Release Phenomena) all subjects in this will receive baseline treatment include Therapeutic Ultrasound 10 minutes, then Mulligan’s Pain Release Phenomena. PRP will apply for 6 weeks .</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain in thumb movements will be primary outcome variable. Timepoint: Pain level will measured before applying the intervention and then after 6 weeks after the completion of intervention. Method of measurement: Numeric Pain Rating Scale  and Patient Rated Wrist Evaluation will be used.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Faisalabad</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-07</approval_date>
        <contact_name>Ethics Committee of The University of Faisalabad.</contact_name>
        <contact_address>4-km, Sargodha Road, University Town, Faisalabad. Faisalabad Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
